{"title":"ASRM 修正案：我们能否放弃 \"治疗天堂\"？","authors":"Tsunakuni Ikka, Taichi Hatta, Misao Fujita","doi":"10.1016/j.stemcr.2024.10.006","DOIUrl":null,"url":null,"abstract":"<p><p>The key amendment to the Act on the Safety of Regenerative Medicine in June 2024 is regarding on-site inspections and the criteria for disqualifying the Certified Special Committees for Regenerative Medicine and Certified Committees for Regenerative Medicine. Appropriate regulations are needed after the legal amendment to stop the widespread use of unproven interventions and move away from the concept of a \"Therapeutic Haven.\"</p>","PeriodicalId":21885,"journal":{"name":"Stem Cell Reports","volume":" ","pages":""},"PeriodicalIF":5.9000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Amendments to ASRM: Can we move away from a \\\"Therapeutic Haven\\\"?\",\"authors\":\"Tsunakuni Ikka, Taichi Hatta, Misao Fujita\",\"doi\":\"10.1016/j.stemcr.2024.10.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The key amendment to the Act on the Safety of Regenerative Medicine in June 2024 is regarding on-site inspections and the criteria for disqualifying the Certified Special Committees for Regenerative Medicine and Certified Committees for Regenerative Medicine. Appropriate regulations are needed after the legal amendment to stop the widespread use of unproven interventions and move away from the concept of a \\\"Therapeutic Haven.\\\"</p>\",\"PeriodicalId\":21885,\"journal\":{\"name\":\"Stem Cell Reports\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2024-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem Cell Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.stemcr.2024.10.006\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL & TISSUE ENGINEERING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cell Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.stemcr.2024.10.006","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
Amendments to ASRM: Can we move away from a "Therapeutic Haven"?
The key amendment to the Act on the Safety of Regenerative Medicine in June 2024 is regarding on-site inspections and the criteria for disqualifying the Certified Special Committees for Regenerative Medicine and Certified Committees for Regenerative Medicine. Appropriate regulations are needed after the legal amendment to stop the widespread use of unproven interventions and move away from the concept of a "Therapeutic Haven."
期刊介绍：
Stem Cell Reports publishes high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine. Our particular focus on shorter, single-point articles, timely publication, strong editorial decision-making and scientific input by leaders in the field and a "scoop protection" mechanism are reasons to submit your best papers.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
